Apria, Inc. provides integrated home healthcare equipment and related services in the United States. The company offers home respiratory therapies, including the supply of stationary and portable home oxygen equipment, and non-invasive ventilators; obstructive sleep apnea therapy devices comprising continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services; and negative pressure wound therapy products. It also provides a range of home medical equipment and other products, and services for patients with home care needs; and clinical and administrative support services, and related products and supplies to patients. The company was incorporated in 2018 and is headquartered in Indianapolis, Indiana.
IPO Year: 2021
Exchange: NASDAQ
Website: apria.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/11/2022 | $37.50 | Buy → Neutral | UBS |
| 1/10/2022 | $39.00 | Buy | Citigroup |
| 11/19/2021 | $39.00 | Buy | Citigroup |
| 11/8/2021 | $43.00 | Buy | Citigroup |
| 7/19/2021 | $32.00 → $29.00 | Buy → Neutral | Goldman Sachs |
| 6/30/2021 | $33.00 | Buy | Citigroup |
INDIANAPOLIS, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR), a leading provider of integrated home healthcare equipment and related services in the United States, announced today financial results for the fourth quarter and full year ended December 31, 2021. As previously announced, the Company will not be hosting a conference call to discuss its financial results. "We reported solid fourth quarter financial results and 2021 was a good year for Apria. Our team did an excellent job operating and executing at a high level while navigating the challenges from the COVID-19 pandemic, as well as a major product recall and supply chain constraints. Fourth
INDIANAPOLIS, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR), a leading provider of home medical equipment, supplies and related services in the United States, announced today that the waiting period has expired under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with its previously announced transaction with Owens & Minor, Inc. The closing of the transaction remains subject to approval by holders of a majority of the Company's outstanding common stock and other customary closing conditions. About Apria Apria is a leading provider of integrated home healthcare equipment and related services in the United States,
Highly Complementary Transaction Expands Patient Direct Offering Year-One Accretion Across Key Financial Metrics and Free Cash Flow Enhancement Creates a Leading Platform for Future Growth Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) and Apria, Inc. ("Apria") (NASDAQ:APR) today announced that the companies have entered into a definitive agreement pursuant to which Owens & Minor will acquire Apria for $37.50 in cash per share of common stock, representing an equity value of approximately $1.45 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220110005291/en/ "I'm very excited about the acquisition of Apria, which wil
INDIANAPOLIS, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR) announced today the completion of a secondary offering of 4,500,000 shares of Apria common stock by a selling stockholder affiliated with Blackstone at a price to the public of $31.50 per share, resulting in gross proceeds of $141.75 million. The selling stockholder has also granted the underwriters an option, exercisable for 30 days from November 10, 2021, to purchase up to an additional 675,000 shares of Class A common stock. Apria did not offer any shares of its common stock and did not receive any net proceeds from the sale of common stock by the selling stockholder. Citigroup and Goldm
INDIANAPOLIS, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR) announced today the pricing of a previously announced secondary offering of 4,500,000 shares of Apria common stock by a selling stockholder affiliated with Blackstone at a price to the public of $31.50 per share. The selling stockholder has also granted the underwriters a 30-day option to purchase up to 675,000 additional shares of common stock. The offering is expected to close on November 15, 2021, subject to customary closing conditions. Apria is not offering any shares of its common stock and will not receive any net proceeds from the sale of common stock by the selling stockholder. Cit
INDIANAPOLIS, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR) announced today that a selling stockholder affiliated with Blackstone has commenced a secondary offering of 4,500,000 shares of Apria common stock. In connection with the offering, the selling stockholder intends to grant the underwriters a 30-day option to purchase up to an additional 675,000 shares of common stock. Apria is not offering any shares of its common stock and will not receive any net proceeds from the sale of common stock by the selling stockholder. Citigroup and Goldman Sachs & Co. LLC are acting as joint lead book-running managers for the offering. Citizens Capital Markets
INDIANAPOLIS, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR), a leading provider of integrated home healthcare equipment and related services in the United States, announced today financial results for the third quarter ended September 30, 2021. "We delivered solid third quarter 2021 financial results that were reflective of our continued execution and operational improvements building on momentum from the first half of the year, despite external headwinds. Third quarter revenue was in-line with our guidance while Adjusted EBITDA and Adjusted EBITDA less Patient Equipment Capex were at the high end or better than our forecast," said Dan Starck, CEO o
INDIANAPOLIS, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR) announced today that it will release fiscal third quarter 2021 financial results on Thursday, November 4, 2021 after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. (ET) on the same day. Conference Call Details The conference call can be accessed by dialing (833) 362-0207 for U.S. participants, or (914) 987-7676 for international participants, referencing conference ID 4161279; or via a live audio webcast that will be available online at https://ir.apria.com/. A replay of the call will be available via webcast for on-demand listeni
INDIANAPOLIS, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR), a leading provider of home medical equipment, supplies and related services in the United States, announced today the appointment of Christopher G. Lee as Chief Accounting Officer, a newly created position. Mr. Lee will report to Debra Morris, Apria's Chief Financial Officer. Mr. Lee has 18 years of accounting and financial leadership experience. He joined Apria in February 2009 and has risen internally to his most recent role as Senior Vice President, Accounting and Finance. Prior to joining Apria, Mr. Lee was with Deloitte & Touche. Mr. Lee is a graduate of the University of California a
INDIANAPOLIS, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR), a leading provider of integrated home healthcare equipment and related services in the United States, announced today financial results for the second quarter ended June 30, 2021. "We delivered another strong quarter as our second quarter 2021 financial results were ahead of our expectations on all three of our key metrics, achieving organic net revenue growth of over 6.0% as compared to the prior year quarter," said Dan Starck, CEO of Apria. "On July 30, we signed a definitive agreement to acquire Airway Breathing Co., a provider of respiratory care services, sleep equipment and supplies,
Highly Complementary Transaction Expands Patient Direct Offering Year-One Accretion Across Key Financial Metrics and Free Cash Flow Enhancement Creates a Leading Platform for Future Growth Owens & Minor, Inc. ("Owens & Minor") (NYSE:OMI) and Apria, Inc. ("Apria") (NASDAQ:APR) today announced that the companies have entered into a definitive agreement pursuant to which Owens & Minor will acquire Apria for $37.50 in cash per share of common stock, representing an equity value of approximately $1.45 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220110005291/en/ "I'm very excited about the acquisition of Apria, which wil
INDIANAPOLIS, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR) announced today that it will release fiscal third quarter 2021 financial results on Thursday, November 4, 2021 after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. (ET) on the same day. Conference Call Details The conference call can be accessed by dialing (833) 362-0207 for U.S. participants, or (914) 987-7676 for international participants, referencing conference ID 4161279; or via a live audio webcast that will be available online at https://ir.apria.com/. A replay of the call will be available via webcast for on-demand listeni
INDIANAPOLIS, July 22, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR) announced today that it will release fiscal second quarter 2021 financial results on Thursday, August 5, 2021 after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. (ET) on the same day. Conference Call Details The conference call can be accessed by dialing (833) 362-0207 for U.S. participants, or (914) 987-7676 for international participants, referencing conference ID # 5380517; or via a live audio webcast that will be available online at https://ir.apria.com/. A replay of the call will be available via webcast for on-demand listen
SC 13G/A - Apria, Inc. (0001735803) (Subject)
SC 13G - Apria, Inc. (0001735803) (Subject)
SC 13G - Apria, Inc. (0001735803) (Subject)
SC 13G/A - Apria, Inc. (0001735803) (Subject)
SC 13G/A - Apria, Inc. (0001735803) (Subject)
SC 13G - Apria, Inc. (0001735803) (Subject)
SC 13G - Apria, Inc. (0001735803) (Subject)
SC 13G - Apria, Inc. (0001735803) (Subject)
SC 13G - Apria, Inc. (0001735803) (Subject)
UBS downgraded Apria from Buy to Neutral and set a new price target of $37.50
Citigroup resumed coverage of Apria with a rating of Buy and set a new price target of $39.00
Citigroup resumed coverage of Apria with a rating of Buy and set a new price target of $39.00
Citigroup resumed coverage of Apria with a rating of Buy and set a new price target of $43.00
Goldman Sachs downgraded Apria from Buy to Neutral and set a new price target of $29.00 from $32.00 previously
Citigroup resumed coverage of Apria with a rating of Buy and set a new price target of $33.00
Citigroup initiated coverage of Apria with a rating of Buy and set a new price target of $33.00
The Goldman Sachs Group initiated coverage of Apria with a rating of Buy and set a new price target of $30.00
4 - Apria, Inc. (0001735803) (Issuer)
4 - Apria, Inc. (0001735803) (Issuer)
4 - Apria, Inc. (0001735803) (Issuer)
4 - Apria, Inc. (0001735803) (Issuer)
4 - Apria, Inc. (0001735803) (Issuer)
4 - Apria, Inc. (0001735803) (Issuer)
4 - Apria, Inc. (0001735803) (Issuer)
4 - Apria, Inc. (0001735803) (Issuer)
4 - Apria, Inc. (0001735803) (Issuer)
4 - Apria, Inc. (0001735803) (Issuer)
15-12B - Apria, Inc. (0001735803) (Filer)
25-NSE - Apria, Inc. (0001735803) (Subject)
S-8 POS - Apria, Inc. (0001735803) (Filer)
8-K - Apria, Inc. (0001735803) (Filer)
10-K/A - Apria, Inc. (0001735803) (Filer)
8-K - Apria, Inc. (0001735803) (Filer)
DEFA14A - Apria, Inc. (0001735803) (Filer)
8-K - Apria, Inc. (0001735803) (Filer)
10-K - Apria, Inc. (0001735803) (Filer)
8-K - Apria, Inc. (0001735803) (Filer)
INDIANAPOLIS, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the "Company" or "Apria") (NASDAQ:APR), a leading provider of home medical equipment, supplies and related services in the United States, announced today the appointment of Christopher G. Lee as Chief Accounting Officer, a newly created position. Mr. Lee will report to Debra Morris, Apria's Chief Financial Officer. Mr. Lee has 18 years of accounting and financial leadership experience. He joined Apria in February 2009 and has risen internally to his most recent role as Senior Vice President, Accounting and Finance. Prior to joining Apria, Mr. Lee was with Deloitte & Touche. Mr. Lee is a graduate of the University of California a